Characteristics of the patients
| . | Total . | APA+ . | APA− . | P . |
|---|---|---|---|---|
| Number of patients | 82 | 31 | 51 | |
| Median age, y | 31 (16-70) | 33 (16-66) | 31 (20-70) | |
| Male/female | 16/66 | 4/27 | 12/39 | NS |
| Initial platelet count | ||||
| 0-50 × 109 | 62 (75.6%) | 22 (70.9%) | 40 (78.4%) | NS |
| 51-100 × 109 | 15 (18.2%) | 8 (25.8%) | 7 (13.7%) | NS |
| 101-140 × 109 | 5 (6%) | 1 (3.2%) | 4 (7.8%) | NS |
| Response to therapy | ||||
| No therapy | 11 (13.4%) | 8 (25.8%) | 3 (5.8%) | .017 |
| CR with MP | 26 (31.7%) | 7 (22.5%) | 19 (37.2%) | NS |
| PR with MP | 22 (26.8%) | 12 (38.7%) | 10 (19.6%) | NS |
| Splenectomy | 19 (23.1%) | 4 (12.9%) | 15 (29.4%) | NS |
| Others | 4 (4.8%) | 0 | 4 (7.8%) | NS |
| . | Total . | APA+ . | APA− . | P . |
|---|---|---|---|---|
| Number of patients | 82 | 31 | 51 | |
| Median age, y | 31 (16-70) | 33 (16-66) | 31 (20-70) | |
| Male/female | 16/66 | 4/27 | 12/39 | NS |
| Initial platelet count | ||||
| 0-50 × 109 | 62 (75.6%) | 22 (70.9%) | 40 (78.4%) | NS |
| 51-100 × 109 | 15 (18.2%) | 8 (25.8%) | 7 (13.7%) | NS |
| 101-140 × 109 | 5 (6%) | 1 (3.2%) | 4 (7.8%) | NS |
| Response to therapy | ||||
| No therapy | 11 (13.4%) | 8 (25.8%) | 3 (5.8%) | .017 |
| CR with MP | 26 (31.7%) | 7 (22.5%) | 19 (37.2%) | NS |
| PR with MP | 22 (26.8%) | 12 (38.7%) | 10 (19.6%) | NS |
| Splenectomy | 19 (23.1%) | 4 (12.9%) | 15 (29.4%) | NS |
| Others | 4 (4.8%) | 0 | 4 (7.8%) | NS |
NS indicates not significant; CR, complete remission; MP, methylprednisolone; PR, partial remission.